CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
1-Year Return
18.35%
This Quarter Return
+2.5%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$6.99B
AUM Growth
-$13.9M
(-0.2%)
Cap. Flow
-$136M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
60.07%
Holding
150
New
17
Increased
52
Reduced
37
Closed
23
Top Buys
| 1 |
Sensata Technologies
ST
|
$172M |
| 2 |
Cigna
CI
|
$20.5M |
| 3 |
Cooper Companies
COO
|
$16.3M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$11.8M |
| 5 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$11.7M |
Top Sells
| 1 |
PX
Praxair Inc
PX
|
$228M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$52.4M |
| 3 |
Viatris
VTRS
|
$20.6M |
| 4 |
HDFC Bank
HDB
|
$17.6M |
| 5 |
Pfizer
PFE
|
$16M |
Sector Composition
| 1 | Financials | 33.54% |
| 2 | Healthcare | 25.68% |
| 3 | Communication Services | 15.95% |
| 4 | Consumer Discretionary | 11.33% |
| 5 | Industrials | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Centene
CNC
$14B
| $27.9M | 0.4% |
693,200
+59,600
| +9% | +$2.4M |
|
27
ICICI Bank
IBN
$113B
| $26.8M | 0.38% |
2,824,459
+75,240
| +3% | +$713K |
|
|
CEMP
28
DELISTED
Cempra, Inc.
CEMP
| $25.9M | 0.37% |
754,300
+184,300
| +32% | +$6.33M |
|
|
TTPH
29
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $23.3M | 0.33% |
24,600
+300
| +1% | +$285K |
|
|
EGRX
30
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $22.6M | 0.32% |
279,407
+145,000
| +108% | +$11.7M |
|
31
Merck
MRK
$207B
| $21M | 0.3% |
385,870
-104,800
| -21% | -$5.69M |
|
|
32
Cigna
CI
$80.7B
| $20.5M | 0.29% |
+126,600
| New | +$20.5M |
|
33
Cencora
COR
$57.1B
| $20.3M | 0.29% |
191,200
+4,300
| +2% | +$457K |
|
|
ESRX
34
DELISTED
Express Scripts Holding Company
ESRX
| $19M | 0.27% |
213,701
+9,100
| +4% | +$809K |
|
|
35
Pfizer
PFE
$139B
| $18.8M | 0.27% |
589,518
-502,758
| -46% | -$16M |
|
36
Jazz Pharmaceuticals
JAZZ
$7.78B
| $17.9M | 0.26% |
101,787
+1,000
| +1% | +$176K |
|
37
AbbVie
ABBV
$374B
| $17.5M | 0.25% |
260,000
| – | – |
|
|
38
Cooper Companies
COO
$13.4B
| $16.3M | 0.23% |
+367,200
| New | +$16.3M |
|
|
39
Teva Pharmaceuticals
TEVA
$21.3B
| $13.9M | 0.2% |
236,000
+200,000
| +556% | +$11.8M |
|
40
HCA Healthcare
HCA
$97.2B
| $13.5M | 0.19% |
149,275
| – | – |
|
|
AIRM
41
DELISTED
Air Methods Corp
AIRM
| $13.4M | 0.19% |
325,136
-10,000
| -3% | -$413K |
|
|
CMRX
42
DELISTED
Chimerix, Inc.
CMRX
| $12.7M | 0.18% |
274,000
+29,000
| +12% | +$1.34M |
|
|
SHPG
43
DELISTED
Shire pic
SHPG
| $11.2M | 0.16% |
46,209
| – | – |
|
44
Alibaba
BABA
$313B
| $10.4M | 0.15% |
+126,320
| New | +$10.4M |
|
45
BioMarin Pharmaceuticals
BMRN
$10.9B
| $10.2M | 0.15% |
74,885
| – | – |
|
46
Baidu
BIDU
$33.6B
| $10.1M | 0.14% |
50,625
+1,710
| +3% | +$340K |
|
47
Zimmer Biomet
ZBH
$20.8B
| $8.68M | 0.12% |
81,824
| – | – |
|
48
Nike
NKE
$111B
| $8.24M | 0.12% |
152,480
+2,400
| +2% | +$130K |
|
49
DaVita
DVA
$9.76B
| $7.83M | 0.11% |
98,491
| – | – |
|
|
ALXN
50
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $7.6M | 0.11% |
42,061
-4,600
| -10% | -$832K |
|